Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluticasone furoate dose proportionality and absolute bioavailability crossover study
NL-OMON37181Active, not recruiting
- Sponsor
- GSK
- Start
- Sep 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of fluticasone in asthma and allergic rhinitis (AR) (4 arms), sponsored by GSK. Primary endpoints: Plasma drug concentrations, Adverse events and 1 more. Started Sep 2012; status: active, not recruiting.
02
Drugs
fluticasone
03
Conditions
asthmaallergic rhinitis (AR)
Beyond the preview
Go deeper on NL-OMON37181.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON37181.